webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide

  CAS No.: 1225972-65-5   Cat No.: BADC-00539 4.5  

N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide is an aldehyde ADC linker optimized for selective bioorthogonal antibody conjugation. It enhances site-specific drug attachment and targeted payload delivery in ADCs.

N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide

Structure of 1225972-65-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H14ClNO3
Molecular Weight
303.74
Shipping
-20°C (International: -20°C)

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
N-[2-(2-chlorophenoxy)ethyl]-4-formylbenzamide
Canonical SMILES
C1=CC=C(C(=C1)OCCNC(=O)C2=CC=C(C=C2)C=O)Cl
InChI
InChI=1S/C16H14ClNO3/c17-14-3-1-2-4-15(14)21-10-9-18-16(20)13-7-5-12(11-19)6-8-13/h1-8,11H,9-10H2,(H,18,20)
InChIKey
ZRPBJYUHAVJCMF-UHFFFAOYSA-N
Shipping
-20°C (International: -20°C)

Potential in Medicinal Chemistry: N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide is a promising compound in the field of medicinal chemistry, particularly in the development of bioactive molecules. The structure of this compound, featuring the chloro-phenoxy and formylbenzamide functional groups, makes it a valuable scaffold for the synthesis of selective enzyme inhibitors. It is being studied for its potential in targeting a variety of enzymes involved in cellular signaling and disease progression. For example, this compound’s ability to interact with enzymes such as kinases or proteases is being explored for the treatment of diseases like cancer, autoimmune disorders, and inflammation. The reactivity of the formylbenzamide group enhances its potential for modifying key biological pathways, making it a versatile candidate in drug design.

Role in Drug Delivery Systems: N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide shows great potential in drug delivery systems. The chloro-phenoxyethyl side chain enhances its solubility in both organic and aqueous environments, making it a good candidate for inclusion in nanoparticles, liposomes, or other nanocarriers. These drug delivery systems benefit from the compound's ability to improve stability and control the release of drugs, ensuring more effective targeting of diseased tissues. This makes N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide particularly useful for treating cancers or other chronic conditions where precision in drug delivery is critical. Additionally, its molecular structure offers flexibility in designing targeted therapies with enhanced bioavailability.

Applications in Protein and Enzyme Inhibition: Another important application of N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide is in the inhibition of specific proteins or enzymes. The formylbenzamide moiety is known to interact with a variety of biological targets, including protein kinases, which are often dysregulated in diseases like cancer and neurodegenerative disorders. By modifying these proteins, the compound has the potential to either block or regulate their activity, providing a new approach to disease treatment. Researchers are actively investigating its use in high-throughput screening for novel enzyme inhibitors, as it shows promise in modulating enzyme function, thereby offering a pathway for the discovery of new drug candidates.

Contribution to Anti-inflammatory Research: Given its bioactive properties, N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide is also being explored for its potential in anti-inflammatory research. The compound’s structure is conducive to modulating inflammatory pathways, which are central to the development of diseases such as rheumatoid arthritis, inflammatory bowel disease, and other autoimmune conditions. By interacting with inflammatory mediators, the compound may help in reducing inflammation and tissue damage, offering a new therapeutic angle for these chronic conditions.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 4-formylphenyl 3-iodo-4-methoxybenzoate | MMAE-[d8] | Mal-Tetra-EG-Osu | Cryptophycin 1 | 20-(tert-Butoxy)-20-oxoicosanoic acid | Ansamitocin P-3 | Boc-(4R)-4-azido-D-proline | MC-VC-PAB-Tubulysin M | t-Boc-N-amido-PEG1-NHS ester | Distamycin A | N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket